Tuscan study on the appropriateness of fresh-frozen plasma transfusion (TuSAPlaT)

Blood Transfusion

Volumn 5, Issue 2, 2007, Pages 75-84

  Liumbruno, Giancarlo Maria ^a,b   Sodini, Maria Laura ^a   Grazzini, Giuliano ^b  

^a AUSL N 6   (Italy)

^b CRCC Regione ^*  (Italy)

Author keywords

Appropriateness; Audit; Fresh frozen plasma; Transfusion

Indexed keywords

FRESH FROZEN PLASMA;

ARTICLE; BLOOD COMPONENT; HEALTH CARE POLICY; HOSPITAL; HUMAN; MEDICAL AUDIT; MEDICAL DECISION MAKING; MEDICAL EDUCATION; PLASMA TRANSFUSION; PRACTICE GUIDELINE; RISK ASSESSMENT;

EID: 47749148123     PISSN: 17232007     EISSN: None     Source Type: Journal    
DOI: 10.2450/2007.0015-07     Document Type: Article

References (61)

1. Catalano L, Abbonizio F, Giampaolo A, et al. Registro nazionale e regionale del sangue e del plasma. Rapporto 2005. Istituto Superiore di Sanità. Available at: http://www.iss.it/binary/publ/cont/06-30. 1163668346.pdf.
2. Sullivan MT, Cotten R, Read EJ, et al. Blood collection and transfusion in the United States in 2001. Transfusion 2007; 47: 385-94.
3. Greinacher A, Fendrich K, Alpen U, et al. Impact of demographic changes on the blood supply: Mecklenburg-West Pomerania as a model region for Europe. Transfusion 2007; 47: 395-401.
4. Vamvakas EC. Epidemiology of blood transfusion and forecasts of demand for blood. In: Vamvakas EC, editor. Evidence-Based Practice of Transfusion Medicine, Bethesda: American Association of Blood Banks; 2001. p. 177-99.
5. Currie CJ, Patel TC, McEvan P, et al. Evaluation of the future supply and demand for blood products in the United Kingdom National Health Service. Transfus Med 2004; 14: 19-24.
6. Yeh CJ, Wu CF, Hsu WT, et al. Transfusion audit of freshfrozen plasma in southern Taiwan. Vox Sang 2006; 91: 270-4.
7. Catalano L, Abbonizio F, Hassan JH. Registro nazionale e regionale del sangue e del plasma. Rapporto 2001. Istituto Superiore di Sanità. Available at: http://www.iss.it/binary/publ/publi/0315.1109149613.pdf.
8. Catalano L, Abbonizio F, Giampaolo A, et al. Registro nazionale e regionale del sangue e del plasma. Rapporto 2002. Istituto Superiore di Sanità. Available at: http://www.iss.it/binary/publ/publi/0341. 1109236509.pdf.
9. Catalano L, Abbonizio F, Giampaolo A, et al. Registro nazionale e regionale del sangue e del plasma. Rapporto 2003. Istituto Superiore di Sanità. Available at: http://www.iss.it/binary/publ2/cont/04-36. 1140439702.pdf.
10. Catalano L, Abbonizio F, Giampaolo A, et al. Registro nazionale e regionale del sangue e del plasma. Rapporto 2004. Istituto Superiore di Sanità. Available at: http://www.iss.it/binary/publ/cont/05-45. 1141828723.pdf.
11. Lomas J, Anderson GM, Domnick-Pierre K, et al. Do practice guidelines guide practice? The effect of a consensus statement on the practice of physicians. N Engl J Med 1989; 321: 1306-11.
12. McClelland B. Effective use of blood components. In: Murphy MF, Pamphilon DH, editors. Practical Transfusion Medicine, Oxford: Blackwell Science; 2001. p. 65-76.
13. Wilson K, MacDougall L, Ferguson D, et al. The effectiveness of interventions to reduce physician's levels of inappropriate transfusion: what can be learned from a systematic review of the literature. Transfusion 2002; 42: 1224-9.
14. Picinini V, Abbonizio F, Catalano L, et al. Mappa delle strutture trasfusionali esistenti sul territorio nazionale (aggiornamento 2005). Istituto Superiore di Sanità. Available at: http://www.iss.it/binary/publ/cont/ 0394_9303_2006_I_06-S1.1145354064.pdf.
15. O'Shaughnessy DF, Atterbury C, Bolton Maggs P, et al. Guidelines for the use of fresh-frozen plasma, cryoprecipitate and cryosupernatant. Br J Haematol 2004; 126: 11-28.
16. Palo R, Capraro L, Hovilehto S, et al. Population-based audit of fresh frozen plasma transfusion practices. Transfusion 2006; 46: 1921-5.
17. Hui CH, Williams I, Davis K. Clinical audit of the use of fresh frozen plasma and platelets in a tertiary teaching hospital and the impact of a new transfusion request form. Intern Med J 2004; 35: 283-8.
18. Soutar RL, Jobanputra S, Tait RC. A two-phase audit of fresh frozen plasma: a regional approach [letter]. Transfus Med 2004; 14: 75-6.
19. Kakkar N, Kaurt R, Dhanoa J. Improvement in fresh frozen plasma transfusion practice: results of an outcome audit. Transfus Med 2004; 14: 231-5.
20. Schofield WN, Rubin GL, Dean MG. Appropriateness of platelet, fresh frozen plasma and cryoprecipitate transfusion in New South Wales public hospitals. Med J Aust 2003; 178: 117-21.
21. Chng WJ, Tan MK, Kuperan P. An audit of fresh frozen plasma usage in an acute general hospital in Singapore. Singapore Med J 2003; 44: 574-8.
22. Stainsby D, Burrowes-King V. Audits of the appropriate use of fresh frozen plasma. Blood Matters 2002; 10: 7-9. Available at: http://www.blood.co. uk/hospitals/library/pdf/bm10.pdf.
23. Luk C, Eckert KM, Barr RM, et al. Prospective audit of the use of fresh-frozen plasma, based on Canadian Medical Association transfusion guidelines [letter]. Can Med Assoc J 2002; 166: 1539-40.
24. Prathiba R, Jayaranee S, Ramesh JC, et al. An audit of fresh frozen plasma usage in a tertiary referral centre in a developing country. Malays J Pathol 2001; 23: 41-6.
25. Beloeil H, Brosseau M, Benhamou D. Transfusion of fresh frozen plasma (FFP): audit of prescriptions. Ann Fr Anesth Reanim 2001; 20: 686-92.
26. Hameedullah, Khan FA, Kamal RS. Improvement of intraoperative fresh frozen plasma transfusion practice - impact of medical audits and provider education. J Pak Med Assoc 2000; 50: 253-6.
27. Marti-Carvajal AJ, Munoz-Navarro SR, Pena-Marti GE, et al. An audit of appropriate use of blood products in adult patients in a Venezuelan general university hospital. Int J Qual Health Care 1999; 11: 391-5.
28. Jones HP, Jones J, Napier JA, et al. Clinical use of FFP: results of a retrospective process and audit outcome. Transfus Med 1998; 8: 37-41.
29. Tuckfield A, Haeusler MN, Grigg AP, et al. Reduction of inappropriate use of blood products by prospective monitoring of transfusion request forms. Med J Aust 1997; 167: 473-6.
30. Marconi M, Almini D, Pizzi MN, et al. Quality assurance of clinical transfusion practice by implementation of the privilege of blood prescription and computerized prospective audit of blood requests. Transfus Med 1996; 6: 11-9.
31. Cheng G, Wong HF, Chan A, et al. The effects of a self educating blood component request form and enforcements of transfusion guidelines on FFP and platelet usage, Queen Mary Hospital, Hong Kong. British Committee for Standards in Hematology (BCSH). Clin Lab Haematol 1996; 18: 83-7.
32. Schots J, Steenssens L. Blood usage review in a Belgian university hospital. Int J Qual Health Care 1994; 6: 41-5.
33. Thomson A, Contreras M, Knowles S. Blood component treatment: a retrospective audit in five major London hospitals. J Clin Pathol 1991; 44: 734-7.
34. Barnette RE, Fish DJ, Eisenstaedt RS. Modification of fresh-frozen plasma transfusion practices through educational intervention. Transfusion 1990; 30: 253-7.
35. Brien WF, Butler RJ, Inwood MJ. An audit of blood component therapy in a Canadian general teaching hospital. CMAJ 1989; 140: 812-5.
36. Mozes B, Epstein M, Ben-Bassat I, et al. Evaluation of the appropriateness of blood and blood product transfusion using preset criteria. Transfusion 1989; 29: 473-6.
37. Blumberg N, Laczin J, McMican A, et al. A critical survey of fresh-frozen plasma use. Transfusion 1986; 26: 511-3.
38. Hayes SL, Torella F. The role of hospital transfusion committees in blood product conservation. Transfus Med Rev 2004; 18: 93-104.
39. Organizzazione Toscana Trapianti (OTT). Attività di donazione e trapianto di organi, tessuti e cellule nella Regione Toscana. OTT Report 2005. Available at: http://www.salute.toscana.it/sst/ott/pdf/report_ott_2005.pdf .
40. Hasley PB, Lave J, Kapoor WN. The necessary and the unnecessary transfusion: a critical review of reported appropriateness rates and criteria for red cell transfusions. Transfusion 1994; 34: 110-5.
41. Rotschild JM, McGurk S, Honour M, et al. Assessment of education and computerized decision support interventions for improving transfusion practice. Transfusion 2007; 47: 228-39.
42. Kanter MH. The transfusion audit as a tool to improve transfusion practice: a critical appraisal. Transfus Sci 1998; 19: 69-81.
43. Use of blood products for elective surgery in 43 European hospitals. The Sanguis Study Group. Transfus Med 1994; 4: 251-68.
44. Holand L, Sarode R. Should plasma be transfused prophylactically before invasive procedures? Curr Opin Hematol 2006; 13: 447-51.
45. Gajic O, Dzik WH, Toy P. Fresh frozen plasma and platelet transfusion for non bleeding patients in the intensive care unit: benefit or harm? Crit Care Med 2006; 34 (5 Suppl): S170-3.
46. Holland LL, Brooks JP, Toward rational fresh frozen plasma transfusion. Am J Clin Pathol 2006; 126: 133-9.
47. Triulzi DJ. The art of plasma transfusion therapy [editorial]. Transfusion 2006; 46: 1268-70.
48. Adel-Wahab OI, Healy B, Dzick WH. Effect of fresh frozen plasma transfusion on prothrombin time and bleeding in patients with mild coagulation abnormalities. Transfusion 2006; 46: 1279-85.
49. Segal JB, Dzick WH; Transfusion Medicine/Hemostasis Clinical Trials Network. Paucity of studies to support that abnormal coagulation test results predict bleeding in the setting of invasive procedures: an evidence-based review. Transfusion 2005; 45: 1413-25.
50. Holland LL, Foster TM, Marlar RA, et al. Fresh frozen plasma is ineffective for correcting minimally elevated international normalized ratios [letter]. Transfusion 2005; 45: 1234-5.
51. Dara SI, Rana R, Afessa B, et al. Fresh frozen plasma transfusion in critically ill medical patients with coagulopathy. Crit Care Med 2005; 33: 2667-71.
52. Wallis JP, Dzik S. Is fresh frozen plasma overtransfused in the United States? [letter]. Transfusion 2004; 44: 1674-5.
53. Dzick W, Rao A. Why do physicians request fresh frozen plasma? [letter]. Transfusion 2004; 44: 1393-4.
54. Stanworth SJ, Brunskill SJ, Hyde CJ, et al. Is fresh frozen plasma clinically effective? A systematic review of randomised controlled trials. Br J Haematol 2004; 126: 139-52.
55. Zimmermann M, Büscher M, Linhardt C, et al. A survey of blood component use in a German university hospital. Transfusion 1997; 37: 1075-83.
56. Titlestad K, Kristensen T, Jorgensen J, et al. Monitoring transfusion practice - a computerized procedure. Transfus Med 2002; 12: 25-34.
57. Titlestad K, Georgsen J, Jorgensen J, et al. Monitoring transfusion practices at two university hospitals. Vox Sang 2001; 80: 40-7.
58. Santagostino E, Mancuso ME, Morfini M, et al. Solvent/detergent plasma for prevention of bleeding in recessively inherited coagulation disorders: dosing, pharmacokinetics and clinical efficacy. Haematologica 2006; 91: 634-9.
59. Chowdhury P, Saayman UP, Paulus U, et al. Efficacy of standard dose and 30 ml/kg fresh frozen plasma in correcting laboratory parameters of haemostasis in critically ill patients. Br J Haematol 2004; 125: 69-73.
60. Casati G. Clinical governance: an ethical appeal or a management programme? [editorial]. Blood Transfus 2006; 4: 251-64.
61. Dzick WH. The NHLBI Clinical Trials Network in transfusion medicine and hemostasis: an overview. J Clin Apher 2006; 21: 57-9.